Catalyst Pharmaceuticals, Inc. (CPRX): Price and Financial Metrics

Catalyst Pharmaceuticals, Inc. (CPRX)

Today's Latest Price: $4.36 USD

0.18 (-3.96%)

Updated Nov 14 8:53am

Add CPRX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

CPRX Stock Summary

  • The ratio of debt to operating expenses for Catalyst Pharmaceuticals Inc is higher than it is for about just 9.68% of US stocks.
  • With a price/sales ratio of 11.64, Catalyst Pharmaceuticals Inc has a higher such ratio than 90.96% of stocks in our set.
  • As for revenue growth, note that CPRX's revenue has grown 231.66% over the past 12 months; that beats the revenue growth of 97.49% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Catalyst Pharmaceuticals Inc are CHRS, FORM, KN, DZSI, and UTSI.
  • CPRX's SEC filings can be seen here. And to visit Catalyst Pharmaceuticals Inc's official web site, go to
CPRX Daily Price Range
CPRX 52-Week Price Range

CPRX Stock Price Chart More Charts

CPRX Price/Volume Stats

Current price $4.36
Prev. close $4.54
Day low $4.36
Day high $4.36
50-day MA $5.39
200-day MA $4.53
52-week high $7.67
52-week low $1.85
Volume 1,086
Avg. volume 2,011,049
Dividend yield N/A
Market Cap 449.06M

Catalyst Pharmaceuticals, Inc. (CPRX) Company Bio

Catalyst Pharmaceuticals focuses on the development and commercialization of prescription drugs targeting rare neurological diseases and disorders. The company was founded in 2002 and is based in Coral Gables, Florida.

CPRX Latest News Stream

Event/Time News Detail
Loading, please wait...

CPRX Latest Social Stream

Loading social stream, please wait...

View Full CPRX Social Stream

CPRX Price Returns

1-mo -17.19%
3-mo -24.31%
6-mo 15.04%
1-year 55.71%
3-year 282.46%
5-year 63.91%
YTD 127.08%
2018 -50.90%
2017 272.38%
2016 -57.14%
2015 -17.51%
2014 52.31%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5214 seconds.